Chemical Peeling — Cost, Top Hospitals & Success Rates | MyMedicPlus

Chemical peeling is a dermatological procedure in which a chemical exfoliant — typically an acid solution — is applied to the skin to induce controlled injury and removal of superficial to deep skin layers, stimulating regeneration of new skin that is smoother, more evenly pigmented, and less scarred. The treated skin undergoes programmed cell death (chemoexfoliation) at the depth controlled by the specific acid used, its concentration, the number of coats applied, and the application time.

Chemical peels are classified by depth of skin penetration into three categories: superficial peels that affect only the epidermis and papillary dermis; medium-depth peels that penetrate to the mid-reticular dermis; and deep peels that penetrate to the lower reticular dermis. Superficial peels use alpha-hydroxy acids (glycolic acid, lactic acid), salicylic acid (beta-hydroxy acid), mandelic acid, or low-concentration trichloroacetic acid (TCA 10–20%); they cause mild exfoliation, require no downtime, and are suitable for regular maintenance. Medium-depth peels use TCA 35–50% or Jessner's solution followed by TCA 35%; they penetrate deeper, cause several days to two weeks of skin peeling, and effectively treat moderate photoageing, acne scarring, and pigmentation. Deep peels use phenol (carbolic acid), either as Baker-Gordon formula or croton oil-modified phenol — they penetrate to the deep reticular dermis, provide dramatic improvement in severe photoageing and deep wrinkles, but require cardiac monitoring during application, weeks of recovery, and carry significant risks.

Chemical peels are one of the most commonly performed cosmetic skin procedures globally, with over one million performed annually in the United States alone. They are practiced by dermatologists, plastic surgeons, and trained aesthetic practitioners.

Acne vulgaris and post-inflammatory hyperpigmentation (PIH) after acne are among the most common indications for chemical peeling. Salicylic acid peels are particularly effective for acne due to its comedolytic and anti-inflammatory properties, penetrating into follicles to dissolve comedones and reduce P. acnes colonisation. Mandelic acid and glycolic acid peels improve both active acne and PIH, addressing the hyperpigmentation from previous breakouts.

Melasma — patchy brown or greyish hyperpigmentation predominantly affecting the cheeks, forehead, and upper lip, highly prevalent in South Asian, East Asian, Hispanic, and Middle Eastern skin tones — benefits from superficial-medium peels (TCA 20–35%, glycolic acid, or Jessner's solution) combined with skin lightening cream pre- and post-treatment. Moderate-to-severe photoageing — solar lentigines, fine wrinkles, rough skin texture, actinic keratoses — is effectively treated with medium-depth TCA or phenol peels, with large controlled studies showing significant improvement in wrinkle scores and patient satisfaction. Acne scarring (ice-pick, boxcar, and rolling scars) benefits from medium-to-deep peels, though deep scars may require combination with subcision or needling. Seborrhoeic keratoses, flat warts, and dermatosis papulosa nigra in darker skin types may also be treated.

Ideal candidates for chemical peeling are individuals with skin concerns amenable to acid exfoliation — acne, PIH, melasma, photoageing, or superficial scarring — who have realistic expectations about the degree of improvement achievable with the peel depth proposed. Fitzpatrick skin type is a critical consideration: lighter skin types (I–III) tolerate medium and deep peels well with low risk of post-inflammatory hyperpigmentation (PIH) or hypopigmentation; darker skin types (IV–VI) are at higher risk of PIH and post-peel dyspigmentation with medium and deep peels, and are generally better treated with more conservative superficial peels, mandelic acid, or azelaic acid-based protocols.

Contraindications include active herpes labialis (cold sores) — phenol and TCA peels can trigger herpes reactivation requiring pre-treatment antiviral prophylaxis with acyclovir or valacyclovir; active acne with open pustules or inflammatory cysts (increased risk of infection and PIH); recent isotretinoin use within six to twelve months (impairs wound healing and increases scarring risk); pregnancy or breastfeeding (avoid chemical peels due to potential absorption of salicylates and phenol); known allergy to aspirin or salicylates (for salicylic acid peels); and severely immunocompromised status. Fitzpatrick type V–VI patients require assessment by an experienced practitioner to select the safest peel type.

Superficial glycolic acid peels (20–70% glycolic acid) are applied in the clinic for one to five minutes under controlled conditions with careful pH monitoring and neutralised with sodium bicarbonate. They improve skin texture, mild acne, and subtle pigmentation with virtually no downtime — mild redness and flaking for one to two days is typical. A series of four to six treatments at two to four week intervals provides cumulative improvement. Salicylic acid peels (20–30%) self-neutralise and are particularly suited to oily, acne-prone skin.

Medium-depth TCA peels (35–50%) produce a visible white frost (indicating protein denaturation at the appropriate depth) when applied and cause erythema, swelling, and skin peeling over seven to fourteen days. The Jessner-TCA combination — applying Jessner's solution (resorcinol, salicylic acid, lactic acid in ethanol) before TCA — enhances TCA penetration and produces a more uniform medium peel. Results are visible over two to four weeks as new skin regenerates; collagen remodelling continues for three to six months. Patient comfort during procedure is managed with topical anaesthesia, fans, and oral analgesia; sedation is not required.

Phenol or croton oil-modified phenol deep peels (Baker-Gordon formula) are performed under cardiac monitoring due to phenol cardiotoxicity — arrhythmias can occur during application. The procedure is performed in sections over 60–90 minutes to limit systemic phenol absorption. Recovery involves occlusive dressing for twenty-four to forty-eight hours, then open healing over two to four weeks with significant crusting, weeping, and erythema. Results are dramatic for severe photoageing but at the cost of significant downtime and risks. These peels should only be performed by experienced dermatologists or plastic surgeons.

Chemical peels provide quantifiable and clinically significant improvement in the conditions they target. For acne, controlled trials demonstrate a 40–60% reduction in inflammatory lesion counts after a series of salicylic or glycolic acid peels. For melasma, Tri-luma (hydroquinone-tretinoin-fluocinolone) combined with glycolic or TCA peels achieves significantly greater melasma area and severity index (MASI) reduction than topical therapy alone. For medium-depth TCA peels in photoageing, clinical studies report 60–80% improvement in wrinkle scores, significant lightening of solar lentigines, and improved overall skin texture at six months.

Deep phenol peels remain among the most powerful treatments for severe facial photoageing — reducing fine and deep wrinkles by 60–80%, improving solar lentigines, and providing durable results lasting five to ten or more years in appropriate patients. The Glogau scale of photoageing is a widely used clinical tool for gauging the appropriate peel depth and expected outcomes. Cost-effectiveness for conditions such as melasma and acne PIH — where multiple laser sessions would otherwise be required — makes chemical peeling particularly attractive, especially for patients in medical tourism destinations where peels are highly cost-competitive.

Post-inflammatory hyperpigmentation (PIH) is the most common complication of chemical peeling, particularly in darker skin types (Fitzpatrick IV–VI) after medium or deep peels. PIH appears as darkened patches in the treated areas weeks to months after peeling and is treated with hydroquinone, kojic acid, azelaic acid, and sun avoidance. The risk is reduced by careful patient selection, pre-conditioning with tretinoin and hydroquinone for four to six weeks before medium peels, and strict sun protection post-peel. Conversely, hypopigmentation — permanent lightening of treated skin — is a risk of deep phenol peels, creating a lighter band of skin at the peel border that is cosmetically evident and irreversible.

Infection — bacterial (Staphylococcus aureus), viral (herpes simplex reactivation), or fungal (Candida) — is a risk for medium and deep peels due to barrier disruption. Herpes prophylaxis with acyclovir 400 mg three times daily from the day before a medium-to-deep peel for seven to fourteen days is standard practice. Scarring from over-penetration of a peel — particularly with TCA above 50% or improper technique — is an uncommon but significant complication, particularly around the perioral region and mandible where the skin is thinner. Cardiac arrhythmia during phenol peel application is managed by pre-operative cardiac screening, continuous ECG monitoring, and slow, segmental application. Systemic toxicity from high-dose phenol absorption is a specific risk of full-face phenol peels.

After a superficial peel, recovery involves mild redness and flaking for one to two days; most patients return to work or social activities the same day or next day. Sun avoidance and high-SPF broad-spectrum sunscreen are mandatory for the following four to six weeks. After a medium-depth TCA peel, the skin peels visibly for seven to fourteen days; patients are advised to stay home during this period. Petroleum jelly or a silicone-based ointment is applied to the healing skin twice daily to maintain moisture and protect the new epidermis. Make-up can be applied once the skin has fully re-epithelialised, typically at ten to fourteen days.

After a deep phenol peel, recovery is two to four weeks of active healing with occlusive dressings, persistent erythema lasting two to three months, and sun avoidance for six to twelve months. The new skin is initially very sensitive and must be protected from sun exposure permanently or indefinitely to avoid re-pigmentation. Maintenance of peel results requires long-term use of tretinoin (retinol), antioxidants, and broad-spectrum sunscreen. Repeat superficial peels can be performed every four to six weeks for maintenance; medium-depth peels annually; deep peels are typically a once-in-a-decade or once-in-a-lifetime procedure for suitable patients.

In the United States, a superficial glycolic or salicylic acid peel costs USD 150–400 per session; a medium-depth TCA peel USD 500–1,500; a deep phenol peel USD 2,000–5,000. A full series of six superficial peels for acne management can cost USD 900–2,400. In the UK, prices are broadly similar: superficial GBP 80–200 per session; medium TCA GBP 300–800; deep phenol GBP 1,500–4,000. These procedures are not covered by most insurance plans as they are classified as cosmetic.

In India — a major medical tourism destination for dermatological and aesthetic procedures — a medium-depth TCA peel at a private dermatology clinic costs USD 50–150; a phenol peel USD 200–600; a series of glycolic peels USD 200–500 for six sessions. Thailand (Bangkok cosmetic clinics) charges USD 80–250 for medium peels; Turkey USD 60–200; Mexico USD 80–250. For patients seeking combination aesthetic treatments — melasma treatment, acne scar improvement, skin rejuvenation — combining a trip to India or Thailand with a series of dermatological peels and ancillary procedures provides exceptional cost savings of 70–90% versus Western prices. Patients should ensure the practitioner is a qualified dermatologist or trained aesthetic physician.

Laser resurfacing — using ablative (CO2, Er:YAG) or non-ablative (fractional 1927 nm thulium, 1550 nm erbium) lasers — delivers controlled thermal energy to remodel collagen and remove damaged epidermis, achieving results comparable to medium-to-deep chemical peels for photoageing and acne scarring. Ablative fractional laser is currently considered the gold standard for acne scar improvement and advanced photoageing at experienced laser centres. Dermabrasion — mechanical abrasion of the skin with a rotating abrasive device — was the precursor to laser resurfacing and is now less commonly performed, though expert dermabrasion surgeons achieve excellent results for acne scarring and perioral rhytids.

Microneedling (collagen induction therapy) using a dermaroller or motorised pen device to create controlled micro-channels in the skin stimulates collagen remodelling, improving skin texture, pore size, and superficial scarring with minimal downtime and low risk of PIH across all skin types. Topical retinoids (tretinoin, adapalene) are the medical cornerstone of photoageing and acne treatment — less dramatic than peels but safe, affordable, and suitable for daily maintenance across all skin types. IPL (intense pulsed light) effectively treats solar lentigines and vascular lesions in photoageing without the peeling downtime of TCA.